Appian insider files Form 144 to sell 50,000 shares

Appian Corporation reported an intended sale of 50,000 Class A common shares by Matthew Calkins under a Form 144 notice.

Rhea-AI Filing Summary

Appian Corporation reported an intended sale of 50,000 Class A common shares by Matthew Calkins under a Form 144 notice. The filing links the sale to a 01/04/2022 stock option exercise with cash settlement and lists a reported sale of 50,000 shares on 06/08/2026 totaling $1,206,275. The notice references Nasdaq and a filing date of 07/07/2026.

Insights

Corporate Governance Analyst

Form 144 notifies the market of an insider sale following an option exercise.

The filing shows Matthew Calkins intends to sell $1,206,275 worth of Class A shares (50,000 shares) tied to a 01/04/2022 stock option exercise. This is a routine disclosure required for certain officer/director sales.

Cash treatment is stated as Cash and the excerpt lists a sale date of 06/08/2026; subsequent filings will show actual transaction settlement details.

Key Figures

Shares to be sold: 50,000 shares Aggregate proceeds: $1,206,275 Exercise date: 01/04/2022 +3 more

6 metrics

Shares to be sold 50,000 shares Class A Common listed in Form 144

Aggregate proceeds $1,206,275 Listed next to 50,000 shares in the excerpt

Exercise date 01/04/2022 Stock Option Exercise date shown

Reported sale date 06/08/2026 Securities sold during the past 3 months entry

Filing reference date 07/07/2026 Date listed in securities header alongside Nasdaq

Broker J.P. Morgan Securities LLC Broker/dealer listed on Form 144 header

Key Terms

Form 144, Stock Option Exercise, Cash settlement

3 terms

Form 144 regulatory

"reported an intended sale of 50,000 Class A common shares"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Stock Option Exercise financial

"01/04/2022 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Cash settlement financial

"01/04/2022 | Cash"

Cash settlement is a process where, instead of exchanging physical assets like stocks or commodities, the parties involved settle the difference in value with money after a contract ends. For investors, it simplifies transactions by avoiding the need to handle or deliver the actual asset, making it quicker and more convenient to complete trades. This method ensures a straightforward way to settle agreements based on their final value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Appian's (APPN) Form 144 report show?

It reports an intended sale of 50,000 Class A shares by Matthew Calkins. The notice links the sale to a stock option exercise dated 01/04/2022 and a reported sale on 06/08/2026 totaling $1,206,275.

Who is the selling party in the Appian Form 144 filing?

The filing identifies Matthew Calkins as the person associated with the sale. The header gives his contact at Appian Corporation and lists the broker as J.P. Morgan Securities LLC with a Nasdaq listing reference.

How many shares and what proceeds are listed in the Form 144 for APPN?

The notice lists 50,000 shares to be sold and shows aggregate proceeds of $1,206,275. The filing also notes a reported sale during the past three months on 06/08/2026 for the same share count.

What type of transaction triggered the Form 144 filing for Appian?

The transaction is identified as a Stock Option Exercise with Cash listed as the settlement method and an exercise date of 01/04/2022, according to the excerpt provided.

Does the Form 144 show when the filing was made for APPN?

The excerpt references 07/07/2026 alongside Nasdaq in the securities header. The sale itself is shown as reported on 06/08/2026 and the exercise date is 01/04/2022.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/07/2026 - 04:28 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001309192
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Appian Corporation
SEC File Number	001-38098
Address of Issuer	7950 Jones Branch Drive McLean, VIRGINIA 22102
Phone	703-442-8844
Name of Person for Whose Account the Securities are To Be Sold	Matthew Calkins
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	CEO and President
Relationship to Issuer	10% Owner

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common	J.P. Morgan Securities LLC 270 Park Avenue - 10th Floor New York NY 10017	50000	1219000	42324735	07/07/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common	01/04/2022	Stock Option Exercise	Issuer			50000	01/04/2022	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Matthew Calkins Care of Appian Corporation 7950 Jones Branch Drive McLean VA 22102	Class A Common	06/08/2026	50000	1206275

144: Remarks and Signature

Remarks
Date of Notice	07/07/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/05/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Matthew Calkins
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)